Accelerated drug development
Maximizing patent utilization can potentially create savings of up to $1.3 million dollars per day (for a blockbuster drug). With this goal in mind, CT-FAST has built-in ability to constantly refine forecasts which allows for increased control over clinical supplies The resulting flexibility in clinical supply operations enables accelerated trial - and therefore overall drug development - execution.
Minimized risk of running out of drug and oversupply
The main lever of any trial supply optimization is the trade-off between oversupply and the risk of undersupplying the trial. CT-Fast provides a robust and accurate solution to measure this trade-off and to find the best balance. Moreover, as soon as cost parameters can be attached to these indicators, CT-Fast determines the optimal cost setup for the trial supply strategy.
Better control of clinical supplies
CT-FAST allows the automatic monitoring of each and every supply movement, whether it is a packaging run, a shipment or a change in an inventory level. Thanks to this improved control of the supply chain the risk of unpredicted and inefficient movements in the supply chain is greatly reduced.
Better allocation of resources
Better control of clinical supplies naturally requires fewer resources allocated to the trial supply chain. This allows pharmaceutical companies to better allocate resources to other valuable tasks and projects, leading to enhanced productivity, performance and profit
Standardized processes
CT-FAST promotes the use of a common language and reference for all clinical trial operations representatives. Because the same information is provided to everyone at the same time and in the same format, standardization of clinical trial processes becomes easier. This results in increased efficiency and control.
